Accès gratuit
Numéro
Med Sci (Paris)
Volume 29, Numéro 12, Décembre 2013
Page(s) 1074 - 1076
Section Nouvelles
DOI http://dx.doi.org/10.1051/medsci/20132912004
Publié en ligne 20 décembre 2013
  1. Mellor RH, Hubert CE, Stanton AW, et al. Lymphatic dysfunction, not aplasia, underlies Milroy disease. Microcirculation 2010 ; 17 : 281–296. [CrossRef] [PubMed]
  2. Petrova TV, Karpanen T, Norrmen C, et al. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat Med 2004 ; 10 : 974–981. [CrossRef] [PubMed]
  3. Mellor RH, Brice G, Stanton AW, et al. Mutations in FOXC2 are strongly associated with primary valve failure in veins of the lower limb. Circulation 2007 ; 115 : 1912–1920. [CrossRef] [PubMed]
  4. Bazigou E, Lyons OT, Smith A, et al. Genes regulating lymphangiogenesis control venous valve formation and maintenance in mice. J Clin Invest 2011 ; 121 : 2984–2992. [CrossRef] [PubMed]
  5. Norrmen C, Ivanov KI, Cheng J, et al. FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1. J Cell Biol 2009 ; 185 : 439–457. [CrossRef] [PubMed]
  6. Sabine A, Agalarov Y, Maby-El Hajjami H, et al. Mechanotransduction, PROX1, and FOXC2 cooperate to control connexin37 and calcineurin during lymphatic-valve formation. Dev Cell 2012 ; 22 : 430–445. [CrossRef] [PubMed]
  7. Tatin F, Taddei A, Weston A, et al. Planar cell polarity protein Celsr1 regulates endothelial adherens junctions and directed cell rearrangements during valve morphogenesis. Dev Cell 2013 ; 26 : 31–44. [CrossRef] [PubMed]
  8. Bazigou E, Xie S, Chen C, et al. Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis. Dev Cell 2009 ; 17 : 175–186. [CrossRef] [PubMed]
  9. Kanady JD, Dellinger MT, Munger SJ, et al. Connexin37 and Connexin43 deficiencies in mice disrupt lymphatic valve development and result in lymphatic disorders including lymphedema and chylothorax. Dev Biol 2011 ; 354 : 253–266. [CrossRef] [PubMed]
  10. Makinen T, Adams RH, Bailey J, et al. PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev 2005 ; 19 : 397–410. [CrossRef] [PubMed]
  11. Levet S, Ciais D, Merdzhanova G, et al. Bone morphogenetic protein 9 (BMP9) controls lymphatic vessel maturation and valve formation. Blood 2013 ; 122 : 598–607. [CrossRef] [PubMed]
  12. Bouvree K, Brunet I, Del Toro R, et al. Semaphorin3A, Neuropilin-1, and PlexinA1 are required for lymphatic valve formation. Circ Res 2012 ; 111 : 437–445. [CrossRef] [PubMed]
  13. Jurisic G, Maby-El Hajjami H, Karaman S, et al. An unexpected role of semaphorin3a-neuropilin-1 signaling in lymphatic vessel maturation and valve formation. Circ Res 2012 ; 111 : 426–436. [CrossRef] [PubMed]